Leveraging the industry’s first industry’s first Precision Engineering Drug Discovery Platform, Orion Biotechnology is transforming the discovery of new medicines to treat a broad range of diseases. Orion’s novel science and technology is unlocking the therapeutic potential and $150B market opportunity of the most highly sought-after drug targets in the industry called G Protein-Coupled Receptors.
